Adipose stromal cells primed with hypoxia and inflammation enhance cardiomyocyte proliferation rate in vitro through STAT3 and Erk1/2

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Przybyt, Ewa ^a   Krenning, Guido ^a   Brinker, Marja G L ^a   Harmsen, Martin C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

ADSC; Cardiomyocyte Proliferation; Erk1 2; Hypoxia; Inflammation; Interleukin 6; Myocardial infarction; STAT3

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUTRALIZING ANTIBODY; RECOMBINANT INTERLEUKIN 6; STAT3 PROTEIN;

ADIPOSE DERIVED STROMAL CELL; ADULT ANIMAL; ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL CYCLE PROGRESSION; CELL HYPOXIA; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; NEWBORN; NONHUMAN; PARACRINE SIGNALING; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STROMA CELL; UPREGULATION;

ADIPOSE TISSUE; ANIMALS; BASE SEQUENCE; CELL PROLIFERATION; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-6; MAP KINASE SIGNALING SYSTEM; MICROSCOPY, FLUORESCENCE; MYOCYTES, CARDIAC; RATS; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; STROMAL CELLS;

EID: 84874530139     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-39     Document Type: Article

References (35)

1. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, Frisen J. Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98-102. 10.1126/science.1164680, 2991140, 19342590.
2. Kajstura J, Rota M, Cappetta D, Ogorek B, Arranto C, Bai Y, Ferreira-Martins J, Signore S, Sanada F, Matsuda A, Kostyla J, Caballero MV, Fiorini C, D'Alessandro DA, Michler RE, Del Monte F, Hosoda T, Perrella MA, Leri A, Buchholz BA, Loscalzo J, Anversa P. Cardiomyogenesis in the aging and failing human heart. Circulation 2012, 126:1869-1881. 10.1161/CIRCULATIONAHA.112.118380, 22955965.
3. Braun T, Dimmeler S. Breaking the silence: stimulating proliferation of adult cardiomyocytes. Dev Cell 2009, 17:151-153. 10.1016/j.devcel.2009.07.022, 19686672.
4. Angert D, Berretta RM, Kubo H, Zhang H, Chen X, Wang W, Ogorek B, Barbe M, Houser SR. Repair of the injured adult heart involves new myocytes potentially derived from resident cardiac stem cells. Circ Res 2011, 108:1226-1237. 10.1161/CIRCRESAHA.110.239046, 3322670, 21454756.
5. Miettinen JA, Ylitalo KV, Niemela M, Kervinen K, Saily M, Koistinen P, Savolainen ER, Makikallio TH, Huikuri HV. Left ventricular functional recovery after intracoronary injection of autologous bone marrow-derived stem cells in patients with acute myocardial infarction: a dose-response pilot study. Int J Cardiol 2011, 154:354-356.
6. Hwang H, Kloner RA. Improving regenerating potential of the heart after myocardial infarction: factor-based approach. Life Sci 2010, 86:461-472. 10.1016/j.lfs.2010.01.004, 20093126.
7. Willems E, Lanier M, Forte E, Lo F, Cashman J, Mercola M. A chemical biology approach to myocardial regeneration. J Cardiovasc Transl Res 2011, 4:340-350. 10.1007/s12265-011-9270-6, 3327297, 21424858.
8. Herrmann JL, Wang Y, Abarbanell AM, Weil BR, Tan J, Meldrum DR. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection. Shock 2010, 33:24-30. 10.1097/SHK.0b013e3181b7d137, 19996917.
9. Herrmann JL, Weil BR, Abarbanell AM, Wang Y, Poynter JA, Manukyan MC, Meldrum DR. IL-6 and TGF-alpha costimulate mesenchymal stem cell vascular endothelial growth factor production by ERK-, JNK-, and PI3K-mediated mechanisms. Shock 2011, 35:512-516. 10.1097/SHK.0b013e31820b2fb9, 21263382.
10. Luo Y, Wang Y, Poynter JA, Manukyan MC, Herrmann JL, Abarbanell AM, Weil BR, Meldrum DR. Pretreating mesenchymal stem cells with interleukin-1beta and transforming growth factor-beta synergistically increases vascular endothelial growth factor production and improves mesenchymal stem cell-mediated myocardial protection after acute ischemia. Surgery 2011, 151:353-363.
11. Atsma DE, Fibbe WE, Rabelink TJ. Opportunities and challenges for mesenchymal stem cell-mediated heart repair. Curr Opin Lipidol 2007, 18:645-649. 10.1097/MOL.0b013e3282f0dd1f, 17993810.
12. Daher SR, Johnstone BH, Phinney DG, March KL. Adipose stromal/stem cells: basic and translational advances: the IFATS collection. Stem Cells 2008, 26:2664-2665. 10.1634/stemcells.2008-0927, 18818434.
13. Kilroy GE, Foster SJ, Wu X, Ruiz J, Sherwood S, Heifetz A, Ludlow JW, Stricker DM, Potiny S, Green P, Halvorsen YD, Cheatham B, Storms RW, Gimble JM. Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol 2007, 212:702-709. 10.1002/jcp.21068, 17477371.
14. Efimenko AI, Starostina EE, Rubina KA, Kalinina NI, Parfenova EV. Viability and angiogenic activity of mesenchymal stromal cells from adipose tissue and bone marrow in hypoxia and inflammation in vitro. Tsitologiia 2010, 52:144-154.
15. Efimenko A, Starostina E, Kalinina N, Stolzing A. Angiogenic properties of aged adipose derived mesenchymal stem cells after hypoxic conditioning. J Transl Med 2011, 9:10. 10.1186/1479-5876-9-10, 3033332, 21244679.
16. Zhang DZ, Gai LY, Liu HW, Jin QH, Huang JH, Zhu XY. Transplantation of autologous adipose-derived stem cells ameliorates cardiac function in rabbits with myocardial infarction. Chin Med J (Engl) 2007, 120:300-307.
17. Yu LH, Kim MH, Park TH, Cha KS, Kim YD, Quan ML, Rho MS, Seo SY, Jung JS. Improvement of cardiac function and remodeling by transplanting adipose tissue-derived stromal cells into a mouse model of acute myocardial infarction. Int J Cardiol 2010, 139:166-172. 10.1016/j.ijcard.2008.10.024, 19046785.
18. Matsushita K, Iwanaga S, Oda T, Kimura K, Shimada M, Sano M, Umezawa A, Hata J, Ogawa S. Interleukin-6/soluble interleukin-6 receptor complex reduces infarct size via inhibiting myocardial apoptosis. Lab Invest 2005, 85:1210-1223. 10.1038/labinvest.3700322, 16056242.
19. Waxman AB, Kolliputi N. IL-6 protects against hyperoxia-induced mitochondrial damage via Bcl-2-induced Bak interactions with mitofusins. Am J Respir Cell Mol Biol 2009, 41:385-396. 10.1165/rcmb.2008-0302OC, 2746985, 19168699.
20. Wuestefeld T, Klein C, Streetz KL, Betz U, Lauber J, Buer J, Manns MP, Muller W, Trautwein C. Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration. J Biol Chem 2003, 278:11281-11288. 10.1074/jbc.M208470200, 12509437.
21. Blindenbacher A, Wang X, Langer I, Savino R, Terracciano L, Heim MH. Interleukin 6 is important for survival after partial hepatectomy in mice. Hepatology 2003, 38:674-682.
22. German CL, Sauer BM, Howe CL. The STAT3 beacon: IL-6 recurrently activates STAT 3 from endosomal structures. Exp Cell Res 2011, 317:1955-1969. 10.1016/j.yexcr.2011.05.009, 21619877.
23. Thangarajah H, Vial IN, Chang E, El-Ftesi S, Januszyk M, Chang EI, Paterno J, Neofytou E, Longaker MT, Gurtner GC. IFATS collection: Adipose stromal cells adopt a proangiogenic phenotype under the influence of hypoxia. Stem Cells 2009, 27:266-274. 10.1634/stemcells.2008-0276, 18974212.
24. McKay BR, De Lisio M, Johnston AP, O'Reilly CE, Phillips SM, Tarnopolsky MA, Parise G. Association of interleukin-6 signalling with the muscle stem cell response following muscle-lengthening contractions in humans. PLoS One 2009, 4:e6027. 10.1371/journal.pone.0006027, 2696599, 19554087.
25. You L, Li L, Xu Q, Ren J, Zhang F. Postconditioning reduces infarct size and cardiac myocyte apoptosis via the opioid receptor and JAK-STAT signaling pathway. Mol Biol Rep 2011, 38:437-443. 10.1007/s11033-010-0126-y, 20349141.
26. Dawn B, Xuan YT, Guo Y, Rezazadeh A, Stein AB, Hunt G, Wu WJ, Tan W, Bolli R. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Cardiovasc Res 2004, 64:61-71. 10.1016/j.cardiores.2004.05.011, 15364614.
27. Bersell K, Arab S, Haring B, Kuhn B. Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 2009, 138:257-270. 10.1016/j.cell.2009.04.060, 19632177.
28. Ieda M, Tsuchihashi T, Ivey KN, Ross RS, Hong TT, Shaw RM, Srivastava D. Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling. Dev Cell 2009, 16:233-244. 10.1016/j.devcel.2008.12.007, 2664087, 19217425.
29. Novoyatleva T, Diehl F, van Amerongen MJ, Patra C, Ferrazzi F, Bellazzi R, Engel FB. TWEAK is a positive regulator of cardiomyocyte proliferation. Cardiovasc Res 2010, 85:681-690. 10.1093/cvr/cvp360, 19887380.
30. Firmbach-Kraft I, Byers M, Shows T, Dalla-Favera R, Krolewski JJ. Tyk2, Prototype of a novel class of Non-receptor tyrosine kinase genes. Oncogene 1990, 5:1329-1336.
31. Fischer P, Hilfiker-Kleiner D. Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis. Basic Res Cardiol 2007, 102:279-297. 10.1007/s00395-007-0658-z, 17530315.
32. Moonen JR, Harmsen MC, Krenning G. Cellular plasticity: the good, the bad, and the ugly? Microenvironmental influences on progenitor cell therapy. Can J Physiol Pharmacol 2012, 90:275-285. 10.1139/y11-107, 22356658.
33. Timmers L, Lim SK, Arslan F, Armstrong JS, Hoefer IE, Doevendans PA, Piek JJ, El Oakley RM, Choo A, Lee CN, Pasterkamp G, de Kleijn DP. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res 2007, 1:129-137.
34. Timmers L, Lim SK, Hoefer IE, Arslan F, Lai RC, van Oorschot AA, Goumans MJ, Strijder C, Sze SK, Choo A, Piek JJ, Doevendans PA, Pasterkamp G, de Kleijn DP. Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res 2011, 6:206-214. 10.1016/j.scr.2011.01.001, 21419744.
35. Lecour S, James RW. When are pro-inflammatory cytokines SAFE in heart failure?. Eur Heart J 2011, 32:680-685. 10.1093/eurheartj/ehq484, 21303780.